NeuroStar Advanced Therapy System (Version 3.8)
Transcranial Magnetic Stimulator. 510(k) K233621, from Neuronetics (Malvern, PA). Product code OBP, class 2.
As of Nov 21, 2026, K233621 is an FDA 510(k) held by Neuronetics, substantially equivalent on Dec 13, 2023 after 30 days, with 1 recall tied to it in FDA's recall database.
- Review time: 30 days
- Recalls: 1
- Cited as a predicate by: 1 device
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
- Neurostar Tms Therapy System, Model 1.1K083538 · Neuronetics · Dec 16, 2008
- Neurostar Tms Therapy SystemK130233 · Neuronetics · Apr 30, 2013
- Neurostar Tms Therapy SystemK133408 · Neuronetics · Mar 28, 2014
- NeuroStar TMS Therapy SystemK160703 · Neuronetics, Inc. · Jun 10, 2016
- NeuroStar TMS Therapy SystemK161519 · Neuronetics, Inc. · Sep 11, 2016
- NeuroStar Advanced TherapyK201158 · Neuronetics, Inc. · Nov 20, 2020
- NeuroStar TMS Therapy System, NeuroStar Advanced Therapy System, NeuroStar, NeuroStar Advanced Therapy for Mental HealthK220127 · Neuronetics, Inc. · Jul 15, 2022
- NeuroStar Advanced Therapy System (Version 3.7)K230029 · Neuronetics · Apr 4, 2023
- NeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced Therapy System, NeuroStar TMS Therapy…K212289 · Neuronetics, Inc. · May 6, 2022
- BTL-699K260691 · BTL Industries, Inc. · Aug 23, 2026
| Started | Recall | Status |
|---|---|---|
| Aug 24, 2026 | Z-0142-2027Cables are not in conformance with the product specifications required in the production of the HP Coil Assembly. | Open |
- KCS rTMS Therapy System (Transcranial Magnetic Stimulator) (MetaStim 100, MetaStim 100A)K260396 · Fidelity BioPharma Co. · Sep 6, 2026
- BTL-699K260691 · BTL Industries, Inc. · Aug 23, 2026
- QuickVision Ultimate rTMSK261228 · Brain Ultimate, Inc. · Aug 14, 2026
- MagVenture Accelerated TMS (aTMS) Therapy SystemK260189 · Tonica Elektronik A/S · May 22, 2026
- Apollo TMS Therapy System;Apollo light TMS Therapy SystemK260560 · Mag & More GmbH · May 22, 2026
- Nexstim Navigated Brain Stimulation (NBS) 6 System (NBS6)K252358 · Nexstim Oyj · Mar 20, 2026
- Nexstim Navigated Brain Stimulation (NBS) 6 System (NBS6)K253098 · Nexstim Oyj · Mar 20, 2026
- SPRY TMS Therapy System (0550)K251653 · Soterix Medical, Inc. · Feb 20, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Nov 13, 2023
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5805
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files